Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02909803Not ApplicableCompleted

Measuring the Glycemic Index and Tracking Metabolites of New and Emerging Lentil Varieties

Role: lead

NCT02907190Not ApplicableCompleted

Glycemic and Insulinemic Impact of Selected Canadian Beans

Role: lead

NCT01547585Not ApplicableCompleted

A Human Trial to Assess the Low Density Lipoprotein Cholesterol (LDL-C) Lowering Effect of Soy

Role: lead

NCT01610518Not ApplicableCompleted

The Glycemic Response Elicited by Beta-glucans of Different Physical Properties and Form

Role: lead

NCT01053793Not ApplicableCompleted

Glycemic Index and Polyphenol Bioavailability of Potatoes

Role: lead

All 5 trials loaded